Literature DB >> 21466360

Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology.

Martin D Ogwang1, Weiqiang Zhao, Leona W Ayers, Sam M Mbulaiteye.   

Abstract

CONTEXT: Burkitt lymphoma (BL) is endemic in Uganda and because of the high incidence, diagnosis is often presumed during clinical care and epidemiologic studies.
OBJECTIVES: To assess the accuracy of the clinical and the local pathology diagnosis of BL as assessed by an outside pathology review diagnosis and to understand the limitations on histopathology practice in a resource-constrained setting at 1 hospital in Uganda.
DESIGN: Clinically presumed pediatric (<15 years) BL cases with biopsies and pathology reports, from 1993 to 2007, were identified at St Mary's Hospital, Lacor (Gulu, Uganda). Local histopathology procedures, hematoxylin-eosin-stained tissue sections, and formalin-fixed paraffin-embedded blocks were reviewed onsite by an outside pathologist, followed by outside study that included tissue microarray immunohistochemistry and in situ hybridization.
RESULTS: Local pathology laboratory procedures were inconsistent and suboptimal, especially for tissue fixation. There were 88 clinically presumed BL cases. Sixty-three could be reviewed by outside pathology (25 cases of lost blocks or no remaining tumor) and showed a clinical diagnostic accuracy of 75% (47 confirmed of 63), with a possible range of 62% to 85%, depending on the actual diagnosis of the 25 nonevaluable cases. There were 64 BL cases diagnosed by local pathology. Forty-five could be reviewed by outside pathology (19 cases of lost blocks or no remaining tumor) and showed a local pathology diagnostic accuracy of 82% (37 confirmed of 45), with a possible range of 58% to 88%, depending on the actual diagnosis of the 19 nonevaluable cases. Non-BL diagnoses included other non-Hodgkin lymphomas, Hodgkin lymphoma, and benign infectious lymphadenopathy.
CONCLUSIONS: Accuracy of clinical diagnosis of BL was reduced by inclusion of other diseases with similar clinical presentations. Local pathology, using morphology alone, only marginally improved clinical accuracy and often could not support outside pathology review due to inadequate laboratory procedures. There is an urgent need to improve pathology services in Uganda before conducting high-quality clinical and epidemiologic studies.

Entities:  

Mesh:

Year:  2011        PMID: 21466360      PMCID: PMC3357109          DOI: 10.5858/2009-0443-EP.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  22 in total

1.  SALIVARY-GLAND TUMORS IN UGANDA.

Authors:  J N DAVIES; D P BURKITT; O G DODGE
Journal:  Cancer       Date:  1964-10       Impact factor: 6.860

2.  Epidemiology of cancer in Africa. Some aspects of the cancer situation in Uganda.

Authors:  J N DAVIES
Journal:  Proc R Soc Med       Date:  1963-07

3.  Commercial formalin substitutes for histopathology.

Authors:  P Prentø; H Lyon
Journal:  Biotech Histochem       Date:  1997-09       Impact factor: 1.718

4.  Non-Hodgkin lymphoma in Uganda: a case-control study.

Authors:  D M Parkin; H Garcia-Giannoli; M Raphael; A Martin; E Katangole-Mbidde; H Wabinga; J Ziegler
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

5.  Geographical distribution of cancer in East Africa: a new clinicopathological approach.

Authors:  M S Hutt; D Burkitt
Journal:  Br Med J       Date:  1965-09-25

6.  A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda.

Authors:  R Newton; J Ziegler; V Beral; E Mbidde; L Carpenter; H Wabinga; S Mbulaiteye; P Appleby; G Reeves; H Jaffe
Journal:  Int J Cancer       Date:  2001-06-01       Impact factor: 7.396

Review 7.  Epidemiology of AIDS-related malignancies an international perspective.

Authors:  Sam M Mbulaiteye; D Maxwell Parkin; Charles S Rabkin
Journal:  Hematol Oncol Clin North Am       Date:  2003-06       Impact factor: 3.722

8.  Estimating HIV prevalence and the impact of HIV/AIDS on a Ugandan hospital by combining serosurvey data and hospital discharge records.

Authors:  Massimo Fabiani; Sandro Accorsi; Robert Aleni; Giuliano Rizzardini; Barbara Nattabi; Antonio Gabrielli; Cyprian Opira; Silvia Declich
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09-01       Impact factor: 3.731

9.  Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.

Authors:  Walter O Mwanda; Jackson Orem; Pingfu Fu; Cecilia Banura; Joweria Kakembo; Caren Auma Onyango; Anne Ness; Sherrie Reynolds; John L Johnson; Vivek Subbiah; Jacob Bako; Henry Wabinga; Fatuma K Abdallah; Howard J Meyerson; Christopher C Whalen; Michael M Lederman; Jodi Black; Leona W Ayers; Edward Katongole-Mbidde; Scot C Remick
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

10.  Cytology and histochemistry of the Burkitt lymphoma.

Authors:  D H WRIGHT
Journal:  Br J Cancer       Date:  1963-03       Impact factor: 7.640

View more
  25 in total

1.  Surgical pathology in sub-Saharan Africa--volunteering in Malawi.

Authors:  Sabina Berezowska; Tamiwe Tomoka; Steve Kamiza; Danny A Milner; Rupert Langer
Journal:  Virchows Arch       Date:  2012-03-10       Impact factor: 4.064

2.  HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.

Authors:  Sam M Mbulaiteye; Kishor Bhatia; Clement Adebamowo; Annie J Sasco
Journal:  Infect Agent Cancer       Date:  2011-10-17       Impact factor: 2.965

3.  Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.

Authors:  Katherine D Westmoreland; Nathan D Montgomery; Christopher C Stanley; Nader Kim El-Mallawany; Peter Wasswa; Toon van der Gronde; Idah Mtete; Mercy Butia; Salama Itimu; Mary Chasela; Mary Mtunda; Coxcilly Kampani; N George Liomba; Tamiwe Tomoka; Bal M Dhungel; Marcia K Sanders; Robert Krysiak; Peter Kazembe; Dirk P Dittmer; Yuri Fedoriw; Satish Gopal
Journal:  Int J Cancer       Date:  2017-03-24       Impact factor: 7.396

Review 4.  Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

Authors:  Kikkeri N Naresh; Martine Raphael; Leona Ayers; Nina Hurwitz; Valeria Calbi; Emily Rogena; Shahin Sayed; Omar Sherman; Hazem A H Ibrahim; Stefano Lazzi; Vasileios Mourmouras; Patricia Rince; Jessie Githanga; Bessie Byakika; Emma Moshi; Muheez Durosinmi; Babatunde J Olasode; Olayiwola A Oluwasola; Effiong E Akang; Yetunde Akenòva; Melissa Adde; Ian Magrath; Lorenzo Leoncini
Journal:  Br J Haematol       Date:  2011-06-28       Impact factor: 6.998

Review 5.  Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.

Authors:  Clement A Adebamowo; Corey Casper; Kishor Bhatia; Sam M Mbulaiteye; Annie J Sasco; Warren Phipps; Sten H Vermund; Susan E Krown
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

6.  Uganda experience-Using cost assessment of an established registry to project resources required to expand cancer registration.

Authors:  Henry Wabinga; Sujha Subramanian; Sarah Nambooze; Phoebe Mary Amulen; Patrick Edwards; Rachael Joseph; Martin Ogwang; Francis Okongo; D Maxwell Parkin; Florence Tangka
Journal:  Cancer Epidemiol       Date:  2016-11-24       Impact factor: 2.984

Review 7.  Pathology-Based Research in Africa.

Authors:  Maria P Lemos; Terrie E Taylor; Suzanne M McGoldrick; Malcolm E Molyneux; Manoj Menon; Steve Kussick; Nonhlanhla N Mkhize; Neil A Martinson; Andrea Stritmatter; Julie Randolph-Habecker
Journal:  Clin Lab Med       Date:  2018-03       Impact factor: 1.935

8.  Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa.

Authors:  Nmazuo W Ozuah; Joseph Lubega; Carl E Allen; Nader Kim El-Mallawany
Journal:  Blood Adv       Date:  2020-08-25

Review 9.  Building capacity for sustainable research programmes for cancer in Africa.

Authors:  Isaac Adewole; Damali N Martin; Makeda J Williams; Clement Adebamowo; Kishor Bhatia; Christine Berling; Corey Casper; Karima Elshamy; Ahmed Elzawawy; Rita T Lawlor; Rosa Legood; Sam M Mbulaiteye; Folakemi T Odedina; Olufunmilayo I Olopade; Christopher O Olopade; Donald M Parkin; Timothy R Rebbeck; Hana Ross; Luiz A Santini; Julie Torode; Edward L Trimble; Christopher P Wild; Annie M Young; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2014-03-11       Impact factor: 66.675

10.  Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory.

Authors:  Jackson Orem; Sven Sandin; Caroline E Weibull; Michael Odida; Henry Wabinga; Edward Mbidde; Fred Wabwire-Mangen; Chris Jlm Meijer; Jaap M Middeldorp; Elisabete Weiderpass
Journal:  Clin Epidemiol       Date:  2012-12-14       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.